Tribune News Service
Chandigarh, March 7
The Chandigarh Group of Colleges (CGC), Landran, has been awarded a grant of Rs 23 lakh from the Indian Council of Medical Research (ICMR) for the development of nanotechnology-based lung cancer vaccine.
Dr Jitender Madan and his team from the College of Pharmacy, CGC Landran, have been awarded this grant. They will be conducting pre-clinical analysis on the subject over a period of three years.
“Lung cancer is among the most common cancers in India and accounts for more deaths than any other type of cancer. Lung cancer is principally caused by cigarette smoking, tobacco chewing in addition to air pollution. As per the WHO statistics, it results in around 1.69 million cancer deaths per year worldwide,” said the college spokesperson.
“This was the reason that encouraged Dr Madan, whose research interest lies in nanobiology of cancer, to take up this project to develop a vaccine to treat this cancer,” added the spokesperson.
Satnam Singh Sandhu, Chairman, CGC Landran, and Rashpal Singh Dhaliwal appreciated the efforts of the team and ensured them CGC’s complete support in undertaking the project.
Most Read
Don't Miss
View All
Top News
129 killed, 180 injured in riot, stampede at football match in Indonesia
Video footage from local news channels show fans streaming o...
Gangster Deepak Tinu involved in Sidhu Moosewala's killing escapes from Mansa CIA custody
Deepak Tinu is a close aide of jailed gangster Lawrence Bish...
4 killed, 1 seriously injured in car accident near Sonadhar in Shimla
Car occupants were on their way to Karewath from Theog when ...
Punjab Govt may hike cane SAP by Rs 20-30 per quintal
Crushing season to begin in Nov | Private mills oppose move,...
We pledge to unite India like Mahatma Gandhi united country against injustice: Rahul
Congress leaders pay homage to the Father of the Nation on h...
